These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T. Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833 [Abstract] [Full Text] [Related]
24. Hepatitis A: from epidemic jaundice to a vaccine-preventable disease. Levinthal G, Ray M. Gastroenterologist; 1996 Jun; 4(2):107-17. PubMed ID: 8792141 [Abstract] [Full Text] [Related]
26. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D. Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952 [Abstract] [Full Text] [Related]
36. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
40. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Das A. Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]